SOHO 2022 | How novel molecular techniques have improved and are providing more insight into the biology of PTCL
Francisco Vega, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into the poor prognosis associated with peripheral T-cell lymphoma (PTCL), and further explains how advances in molecular techniques, including high-throughput sequencing and whole-exome sequencing, have provided clinicians and researchers with a better understanding of this disease. To conclude, Prof. Vega explains how the clinical applicability of these techniques has improved over the years. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
